Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Janssen Pharmaceuticals, Inc.
Current Parent Company: Johnson & Johnson
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $181,000,000
Year: 2012
Date: August 30, 2012
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Mega-Scandal: Improper Drug Marketing
Violation Description: Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson agreed to pay $181 million to resolve multistate litigation alleging improper marketing and advertising of the powerful anti-psychotic drugs Risperdal and Invega.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.